Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
2,131
Value
$102.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVO by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,131$102.2K<0.1%+925+76.7%AddedHolders
Q1 20261,206$44.3K<0.1%−1,019−45.8%ReducedHolders
Q4 20252,225$113.2K<0.1%−293−11.6%ReducedHolders
Q3 20252,518$139.7K<0.1%−346,003−99.3%ReducedHolders
Q2 2025348,521$24.1M0.4%+341,480+4,849.9%AddedHolders
Q1 20257,041$488.9K<0.1%+2,600+58.5%AddedHolders
Q4 20244,441$382.0K<0.1%+316+7.7%AddedHolders
Q3 20244,125$491.2K<0.1%+150+3.8%AddedHolders
Q2 20243,975$567.4K<0.1%+105+2.7%AddedHolders
Q1 20243,870$496.9K<0.1%−56−1.4%ReducedHolders
Q4 20233,926$406.1K<0.1%00.0%UnchangedHolders
Q3 20233,926$357.0K<0.1%00.0%UnchangedConverted for a 2-for-1 splitHolders
Q2 20231,963$317.7K<0.1%−14−0.7%ReducedHolders
Q1 20231,977$314.6K<0.1%+14+0.7%AddedHolders
Q4 20221,963$265.7K<0.1%+28+1.4%AddedHolders
Q3 20221,935$193.0K<0.1%−2−0.1%ReducedHolders
Q2 20221,937$216.0K<0.1%+2+0.1%AddedHolders
Q1 20221,935$215.0K<0.1%00.0%UnchangedHolders
Q4 20211,935$217.0K<0.1%−38−1.9%ReducedHolders
Q3 20211,973$189.0K<0.1%00.0%UnchangedHolders
Q2 20211,973$165.0K<0.1%+205+11.6%AddedHolders
Q1 20211,768$119.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.